by Kaustubh Bagalkote | Mar 27, 2026 | General
Cybersecurity equities faced downward pressure Friday following reports that AI startup Anthropic inadvertently exposed internal data. The lapse allegedly revealed details of an unreleased model, “Claude Mythos,” and an invite-only CEO retreat. Significant Security...
by Piero Cingari | Mar 27, 2026 | General
President Donald Trump paused U.S. strikes on Iranian energy facilities for a second time Thursday, pushing the deadline to April 6 and highlighting that negotiations are “going very well.” Oil markets immediately called his bluff: Brent crude — as tracked by...
by Dylan Berman | Mar 27, 2026 | General
Artelo Biosciences, Inc. (NASDAQ:ARTL) shares are trading higher Friday after the company announced the withdrawal of its SEC Registration Statement as it doesn’t intend to sell securities at this time. Artelo Biosciences stock is surging to new heights today. Why is...
by Anusuya Lahiri | Mar 27, 2026 | General
Meta Platforms, Inc. (NASDAQ:META) is doubling down on its U.S. infrastructure footprint, unveiling plans to expand its El Paso, Texas data center to 1 gigawatt, a move that will push total investment beyond $10 billion while creating hundreds of long-term jobs. Data...
by Avi Kapoor | Mar 27, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BTIG analyst Gregory Lewis initiated coverage on Iperionx Ltd...
by Avi Kapoor | Mar 27, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Barclays analyst Glen Santangelo upgraded Phathom Pharmaceuticals...
Recent Comments